Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses.

Douam F, Ziegler CGK, Hrebikova G, Fant B, Leach R, Parsons L, Wang W, Gaska JM, Winer BY, Heller B, Shalek AK, Ploss A.

Nat Commun. 2018 Nov 28;9(1):5031. doi: 10.1038/s41467-018-07478-2.

2.

Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Winer BY, Shirvani-Dastgerdi E, Bram Y, Sellau J, Low BE, Johnson H, Huang T, Hrebikova G, Heller B, Sharon Y, Giersch K, Gerges S, Seneca K, Pais MA, Frankel AS, Chiriboga L, Cullen J, Nahass RG, Lutgehetmann M, Toettcher JE, Wiles MV, Schwartz RE, Ploss A.

Sci Transl Med. 2018 Jun 27;10(447). pii: eaap9328. doi: 10.1126/scitranslmed.aap9328.

PMID:
29950446
3.

Long-term hepatitis B infection in a scalable hepatic co-culture system.

Winer BY, Huang TS, Pludwinski E, Heller B, Wojcik F, Lipkowitz GE, Parekh A, Cho C, Shrirao A, Muir TW, Novik E, Ploss A.

Nat Commun. 2017 Jul 25;8(1):125. doi: 10.1038/s41467-017-00200-8.

4.

Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.

Shirvani-Dastgerdi E, Winer BY, Celià-Terrassa T, Kang Y, Tabernero D, Yagmur E, Rodríguez-Frías F, Gregori J, Luedde T, Trautwein C, Ploss A, Tacke F.

J Hepatol. 2017 Aug;67(2):246-254. doi: 10.1016/j.jhep.2017.03.027. Epub 2017 Apr 7.

5.

Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.

Winer BY, Huang T, Low BE, Avery C, Pais MA, Hrebikova G, Siu E, Chiriboga L, Wiles MV, Ploss A.

Virology. 2017 Feb;502:63-72. doi: 10.1016/j.virol.2016.12.017. Epub 2016 Dec 19.

6.

In vivo models of hepatitis B and C virus infection.

Winer BY, Ding Q, Gaska JM, Ploss A.

FEBS Lett. 2016 Jul;590(13):1987-99. doi: 10.1002/1873-3468.12157. Epub 2016 Apr 8. Review.

7.

Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.

Thandar M, Lood R, Winer BY, Deutsch DR, Euler CW, Fischetti VA.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2671-9. doi: 10.1128/AAC.02972-15. Print 2016 May.

8.

Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.

Douam F, Gaska JM, Winer BY, Ding Q, von Schaewen M, Ploss A.

Annu Rev Genet. 2015;49:21-45. doi: 10.1146/annurev-genet-112414-054823. Epub 2015 Sep 25. Review.

9.

Breaking the species barrier for hepatitis delta virus.

Winer BY, Ploss A.

Hepatology. 2016 Jan;63(1):334-6. doi: 10.1002/hep.28129. Epub 2015 Oct 29. No abstract available.

10.

Determinants of hepatitis B and delta virus host tropism.

Winer BY, Ploss A.

Curr Opin Virol. 2015 Aug;13:109-16. doi: 10.1016/j.coviro.2015.06.004. Epub 2015 Jul 8. Review.

11.

Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.

Lood R, Winer BY, Pelzek AJ, Diez-Martinez R, Thandar M, Euler CW, Schuch R, Fischetti VA.

Antimicrob Agents Chemother. 2015 Apr;59(4):1983-91. doi: 10.1128/AAC.04641-14. Epub 2015 Jan 20.

12.

Broadly neutralizing antibodies abrogate established hepatitis C virus infection.

de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, Burton DR, Baltimore D, Law M, Rice CM, Ploss A.

Sci Transl Med. 2014 Sep 17;6(254):254ra129. doi: 10.1126/scitranslmed.3009512.

13.

Beyond the chromosome: the prevalence of unique extra-chromosomal bacteriophages with integrated virulence genes in pathogenic Staphylococcus aureus.

Utter B, Deutsch DR, Schuch R, Winer BY, Verratti K, Bishop-Lilly K, Sozhamannan S, Fischetti VA.

PLoS One. 2014 Jun 25;9(6):e100502. doi: 10.1371/journal.pone.0100502. eCollection 2014.

14.

Anthrax SET protein: a potential virulence determinant that epigenetically represses NF-κB activation in infected macrophages.

Mujtaba S, Winer BY, Jaganathan A, Patel J, Sgobba M, Schuch R, Gupta YK, Haider S, Wang R, Fischetti VA.

J Biol Chem. 2013 Aug 9;288(32):23458-72. doi: 10.1074/jbc.M113.467696. Epub 2013 May 29.

15.

Use of a bacteriophage lysin to identify a novel target for antimicrobial development.

Schuch R, Pelzek AJ, Raz A, Euler CW, Ryan PA, Winer BY, Farnsworth A, Bhaskaran SS, Stebbins CE, Xu Y, Clifford A, Bearss DJ, Vankayalapati H, Goldberg AR, Fischetti VA.

PLoS One. 2013 Apr 10;8(4):e60754. doi: 10.1371/journal.pone.0060754. Print 2013.

16.

Structural properties of 2/2 hemoglobins: the group III protein from Helicobacter hepaticus.

Nothnagel HJ, Winer BY, Vuletich DA, Pond MP, Lecomte JT.

IUBMB Life. 2011 Mar;63(3):197-205. doi: 10.1002/iub.430.

17.

Chemical reactivity of Synechococcus sp. PCC 7002 and Synechocystis sp. PCC 6803 hemoglobins: covalent heme attachment and bishistidine coordination.

Nothnagel HJ, Preimesberger MR, Pond MP, Winer BY, Adney EM, Lecomte JT.

J Biol Inorg Chem. 2011 Apr;16(4):539-52. doi: 10.1007/s00775-011-0754-2. Epub 2011 Jan 15.

Supplemental Content

Loading ...
Support Center